Skip to Content

71 CIBA (Ser-ap-ES 25 mg / 15 mg / 0.1 mg)

Generic Name: hydralazine/hydrochlorothiazide/reserpine

Pill imprint 71 CIBA has been identified as Ser-ap-ES 25 mg / 15 mg / 0.1 mg.

Ser-Ap-Es is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. Risk cannot be ruled out during pregnancy. Ser-Ap-Es 25 mg / 15 mg / 0.1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ser-ap-ES 25 mg / 15 mg / 0.1 mg 71 CIBA Front
Ser-ap-ES 25 mg / 15 mg / 0.1 mg 71 CIBA Back
Discount Card Promo
Ser-ap-ES
Generic Name:
hydralazine/hydrochlorothiazide/reserpine
Imprint:
71 CIBA
Strength:
25 mg / 15 mg / 0.1 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antihypertensive combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00083-0071
Inactive Ingredients:
acacia
FD&C Blue No. 1
FD&C Green No. 3
FD&C Red No. 40
FD&C Yellow No. 6
lactose
polyethylene glycol
starch
stearic acid
sucrose

More info Print Imprint Search

More about Ser-Ap-Es (hydralazine / hydrochlorothiazide / reserpine)

Professional resources

Related treatment guides

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide